ECG Technology

HeartBeam to Showcase FDA-Cleared Cardiac Technology at Major Investor Conferences

HeartBeam to Showcase FDA-Cleared Cardiac Technology at Major Investor Conferences

HeartBeam Inc. executives will present the company's innovative cable-free 3D ECG technology at three September investor conferences, highlighting progress in commercializing a device that could transform remote cardiac care.

August 28, 2025
HeartBeam Inc. Honored with 2025 Innovation Award for Pioneering Remote Cardiac Diagnostics

HeartBeam Inc. Honored with 2025 Innovation Award for Pioneering Remote Cardiac Diagnostics

HeartBeam Inc. (NASDAQ: BEAT) has been awarded the 2025 Innovation Award in Remote Cardiac Diagnostics for its FDA-cleared 3D ECG technology, marking a significant advancement in non-clinical cardiac care.

July 23, 2025